非奈利酮在其他方面也具有良好的耐受性,在2个大型试验中未发现严重AKI的额外风险。更多详情参见KDIGO 2022慢性肾脏病糖尿病管理临床实践指南。 与单独使用SGLT2i和非奈利酮相比,评估SGLT2i和非奈利酮联合使用效果的试验正在进行中(Clin-icalTrials.gov:NCT05254002)。尚未对与无糖尿病的CKD患者进行类固醇和nsMRA的有效...
In summary, Class III and Class IV LN are severe diseases that result in AKI that leads to permanent nephron loss if not treated promptly with effective therapeutic regimens. Severe LN is an important, but treatable, cause of patient morbidity and mortality in many parts of the world. Advances...
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns Author links open overlay panelAdeera Levin 1, Sofia B. Ahmed 2, Juan Jesus Carrero 3, Bethany Foster 4, Anna Francis 5, Rasheeda K. ...
Italian AKI Guidelines: The Best of the KDIGO and ADQI Results.doi:10.1159/000439261ClaudioRoncoEBSCO_AspBlood Purification
Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551-61....
Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43: 1551-61.Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. ...
Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial [published online ahead of print January 21, ...
非奈利酮在其他方面也具有良好的耐受性,在2个大型试验中未发现严重AKI的额外风险。更多详情参见KDIGO 2022慢性肾脏病糖尿病管理临床实践指南。 与单独使用SGLT2i和非奈利酮相比,评估SGLT2i和非奈利酮联合使用效果的试验正在进行中(Clin-icalTrials.gov:NCT05254002)。尚未对与无糖尿病的CKD患者进行类固醇和nsMRA的有效...
Abbreviations: AKI, acute kidney injury; CKD, chronic kidney disease; eCLcr, estimated creatinine clearance; eGFR, estimated glomerular filtration rate; mGFR, measured glomerular filtration rate. DRUG DOSING CONSIDERATIONS FOR PATIENTS WITH CKD Despite numerous published guidelines46., 47., 48., 49....
Malaria-related kidney disease mostly manifests as AKI, but GN can also occur. Patients with malarial infection and GN should be treated with an appropriate antiparasitic agent in sufficient dosage and duration to eradicate the organism from blood and hepatosplenic sites. There are no indications fo...